top of page
Search


Communication Campaign Toolkits Released for Naloxone, Fentanyl and MAT Awareness
The HEALing Communities Study (HCS) has developed a series of ready-to-use communication campaigns designed to increase awareness about substance use disorders and effective response strategies to help strengthen local prevention, treatment, recovery, and overdose prevention efforts. These free toolkits make it easy for you to share critical information in your community through social media, radio, print materials, and more. Whether you’re part of a community coalition, loca
Sep 29


JCOIN Study Finds that Providing MAT in Jails Improves Treatment Engagement, Reduces Overdose and Recidivism
In a new study published in The New England Journal of Medicine , researchers with JCOIN’s Massachusetts Clinical Research Center found that providing medications for opioid use disorder (MOUD) during incarceration can improve outcomes and save lives after release. The study shows that individuals who received MOUD in jail were more likely to engage in treatment and less likely to experience an overdose within six months of release. The study evaluated the impact of a 2019 Ma
Sep 17


Telemedicine Patients with Opioid Use Disorder Experience Issues Filling Prescriptions
A study published in JAMA Network Open examined pharmacy barriers faced by patients prescribed buprenorphine to treat opioid use disorder (OUD) through telemedicine. The findings show that pharmacy-related challenges were common, with nearly one-third of study participants (31.9%) reporting going without buprenorphine at some point in the prior 12 months due to pharmacy-related barriers. Researchers surveyed 601 adults who were receiving treatment from a multistate telemedi
Sep 11


One in Four U.S. Jails Offer All FDA-Approved Medications to Treat Opioid Use Disorder, According to JCOIN’s National Survey of Treatment Services in Jails
In a new article published in JAMA, JCOIN researchers found that 27.6% of United States jails offer all three FDA-approved medications for opioid use disorder (MOUD).
Jun 30


Webinar: Expanding Access to Methadone Treatment for Opioid Use Disorder in Carceral Settings
In April 2024, the Substance Abuse & Mental Health Services Administration (SAMHSA) issued a final rule on regulations regarding opioid...
Jun 20, 2024


Massachusetts Bridge Clinics Reduce Barriers to Starting Medication for Opioid Use Disorder
Effective treatments for substance use disorder (SUD) can substantially improve patient outcomes. First-line medications like...
Jun 7, 2024


Correcting Myths about Medications for Opioid Use Disorder
Medications for opioid use disorder (MOUD) help reduce or block the euphoric effects of illicit opioids, decrease opioid craving, and help i
May 4, 2024


Ask the Expert: Medications for Opioid Use Disorder (MOUD)
Dr. John Winhusen featured in the Ask the Expert series explainer on medications for opioid use disorder (MOUD).
Apr 26, 2024


New Report Features 10 Best Practices for Jails and Prisons on Responding to Opioid Use Disorder
Opioid Use Disorder Best Practices for Corrections highlights 10 essential strategies that jails and prisons can use to address the...
Apr 22, 2024


Medications for Opioid Use Disorder Infographic
Medications for opioid use disorder Medications used to treat opioid use disorders are considered the “gold standard” of treatment....
Apr 22, 2023


Study Identifies Key Barriers and Facilitators for MOUD in U.S. Jails
Transitioning to the community following incarceration is a particularly high risk for individuals with opioid use disorder (OUD),...
Mar 23, 2023


Offering Buprenorphine Prior to Release from Jail May Reduce Recidivism
Individuals leaving incarceration with opioid use disorder (OUD) are at a high risk for overdose, recidivism, and adverse health...
Feb 9, 2022
bottom of page




